108 related articles for article (PubMed ID: 650199)
1. A follow-up study on the chemotherapy of neurodermatitis with a monoamine oxidase inhibitor.
Friedman S; Kantor I; Sobel S; Miller R
J Nerv Ment Dis; 1978 May; 166(5):349-57. PubMed ID: 650199
[No Abstract] [Full Text] [Related]
2. On the treatment of neurodermatitis with a monoamine oxidase inhibitor. The chemotherapy of psychosomatic illness through A-REM suppression.
Friedman S; Kantor I; Sobel S; Miller R
J Nerv Ment Dis; 1978 Feb; 166(2):117-25. PubMed ID: 203659
[No Abstract] [Full Text] [Related]
3. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
Georgotas A; McCue RE; Friedman E; Cooper TB
J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
[TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidase inhibitor hypertensive crisis headache and orthostatic hypotension.
Golwyn DH; Sevlie CP
J Clin Psychopharmacol; 1993 Feb; 13(1):77-8. PubMed ID: 8486823
[No Abstract] [Full Text] [Related]
5. Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.
Georgotas A; McCue RE; Hapworth W; Friedman E; Kim OM; Welkowitz J; Chang I; Cooper TB
Biol Psychiatry; 1986 Oct; 21(12):1155-66. PubMed ID: 3756264
[TBL] [Abstract][Full Text] [Related]
6. A clinical overview of monoamine oxidase inhibitors.
Zisook S
Psychosomatics; 1985 Mar; 26(3):240-6, 251. PubMed ID: 3887453
[No Abstract] [Full Text] [Related]
7. Blood pressure effects of phenelzine.
Kronig MH; Roose SP; Walsh BT; Woodring S; Glassman AH
J Clin Psychopharmacol; 1983 Oct; 3(5):307-10. PubMed ID: 6630590
[No Abstract] [Full Text] [Related]
8. Monoamine oxidase inhibitors and sleep movements.
Morgan JL; Brown TM; Wallace ER
Am J Psychiatry; 1994 May; 151(5):782. PubMed ID: 8166329
[No Abstract] [Full Text] [Related]
9. Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients.
Robinson DS; Nies A; Corcella J; Cooper TB; Spencer C; Keefover R
J Clin Psychiatry; 1982 May; 43(5 Pt 2):8-15. PubMed ID: 7042699
[TBL] [Abstract][Full Text] [Related]
10. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
[No Abstract] [Full Text] [Related]
11. Monoamine oxidase-inhibiting antidepressants. A clinical update.
Murphy DL; Sunderland T; Cohen RM
Psychiatr Clin North Am; 1984 Sep; 7(3):549-62. PubMed ID: 6384960
[TBL] [Abstract][Full Text] [Related]
12. Severe daytime somnolence in patients treated with an MAOI.
Teicher MH; Cohen BM; Baldessarini RJ; Cole JO
Am J Psychiatry; 1988 Dec; 145(12):1552-6. PubMed ID: 3273886
[TBL] [Abstract][Full Text] [Related]
13. Phenelzine and amitriptyline in the treatment of depression. A comparison of present and past studies.
Ravaris CL; Robinson DS; Ives JO; Nies A; Bartlett D
Arch Gen Psychiatry; 1980 Sep; 37(9):1075-80. PubMed ID: 7416907
[TBL] [Abstract][Full Text] [Related]
14. Treatment of intractable narcolepsy with a monoamine oxidase inhibitor.
Wyatt RJ; Fram DH; Buchbinder R; Snyder F
N Engl J Med; 1971 Oct; 285(18):987-91. PubMed ID: 4328710
[No Abstract] [Full Text] [Related]
15. Pressor amines and monoamine-oxidase inhibitors for treatment of postural hypotension in autonomic failure. Limitations and hazards.
Davies B; Bannister R; Sever P
Lancet; 1978 Jan; 1(8057):172-5. PubMed ID: 74603
[TBL] [Abstract][Full Text] [Related]
16. The treatment of phenelzine-induced hypotension with salt tablets: case report.
Munjack DJ
J Clin Psychiatry; 1984 Feb; 45(2):89-90. PubMed ID: 6693369
[TBL] [Abstract][Full Text] [Related]
17. Acute psychosis following phenelzine discontinuation.
Liskin B; Roose SP; Walsh BT; Jackson WK
J Clin Psychopharmacol; 1985 Feb; 5(1):46-7. PubMed ID: 3973072
[TBL] [Abstract][Full Text] [Related]
18. A guide for drug use in depressive disorders.
Raskin A
Am J Psychiatry; 1974 Feb; 131(2):181-5. PubMed ID: 4358190
[No Abstract] [Full Text] [Related]
19. Antipyrine elimination by patients under treatment with monoamine oxidase inhibitors.
Smith SE; Lambourn J; Tyrer PJ
Br J Clin Pharmacol; 1980 Jan; 9(1):21-5. PubMed ID: 7356888
[TBL] [Abstract][Full Text] [Related]
20. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
